Invention Grant
- Patent Title: Compositions targeting bradykinin receptor B1 for medical imaging of cancer and other disorders
-
Application No.: US14428249Application Date: 2013-09-13
-
Publication No.: US10039846B2Publication Date: 2018-08-07
- Inventor: Kuo-shyan Lin , Francois Benard , Jinhe Pan , Felix Mesak , Zhengxing Zhang
- Applicant: BRITISH COLUMBIA CANCER AGENCY BRANCH
- Applicant Address: CA
- Assignee: BRITISH COLUMBIA CANCER AGENCY BRANCH
- Current Assignee: BRITISH COLUMBIA CANCER AGENCY BRANCH
- Current Assignee Address: CA
- Agency: Stoel Rives LLP
- Agent Zhi-Xiang (Alex) Oh
- International Application: PCT/CA2013/050707 WO 20130913
- International Announcement: WO2014/040192 WO 20140320
- Main IPC: A61K31/435
- IPC: A61K31/435 ; A61K31/496 ; A61K31/498 ; A61K38/08 ; A61K51/08 ; C07K7/18 ; C07D241/50 ; C07D241/04 ; C07D403/04 ; A61K38/04 ; C07D403/12 ; A61K51/04
Abstract:
Bradykinin B1 receptor (B1R) targeting peptides and compounds are radiolabelled with radioisotopes that are suitable for imaging and/or radiotherapy. The radiolabelled peptides and compounds have utility in imaging tissues expressing or overexpressing B1R and/or treating diseases or conditions in which B1R is expressed or overexpressed, including cancer.
Public/Granted literature
- US20150238641A1 COMPOSITIONS TARGETING BRADYKININ RECEPTOR B1 FOR MEDICAL IMAGING OF CANCER AND OTHER DISORDERS Public/Granted day:2015-08-27
Information query
